International Program Committee

The 2021 Summit International Program & Coordination Committee 

Shahin Gharakhanian, MD, DPH
[Principal & Program Chair]

Co-founder in 2017, Boston-Paris Biotechnology Summit® Principal & Chief Medical Officer Shahin Gharakhanian MD Consulting LLC, CIC: Cambridge Innovation Center Cambridge MA, USA

Thierry Auperin, PhD

Vice-President, Medical Communications, Alnylam Pharmaceuticals, Cambridge MA

Jennifer Bock, JD

Partner (Corporate Law), McDermott Will & Emery, International Law Firm, Boston MA

Vanessa Elharrar, MD

Vice-President Vaccine Business Lead, PPD Biotech, Wilmington NC. Fmr Office of Director, NIH, MD

Omid Harandi, PhD

 Director of Cell and Gene Therapy at Flagship Labs (Cambridge, MA) 

Frederic Jallat, PhD

Professor & Academic Director, Biopharmaceutical Management Program, ESCP Business School, Paris, France

Cecile Le Camus, MD

Fmr Executive Director, Medical Lead Cystic Fibrosis, VERTEX Pharmaceuticals, Boston MA, USA

Retsina Meyer, PhD

Head of Strategic Projects & Alliances, Delix Therapeutics; Board of Advisors, Museum of Science, Boston MA

Nawal Ouzren, MSc

CEO, Sensorion, Board of Directors, Inventiva; Fmr Group Vice-President, Shire Rare Genetic Diseases, Paris Region, France

Kamilla Rolsted, PhD, EMBA

Business Development & Entrepreneur; Senior Executive Consultant; Faculty of Health &  University of Copenhagen; Vice-Chair, Pharmaceutical Society of Denmark, Frederiksberg, Denmark